1. Home
  2. PEBO vs GYRE Comparison

PEBO vs GYRE Comparison

Compare PEBO & GYRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PEBO
  • GYRE
  • Stock Information
  • Founded
  • PEBO 1902
  • GYRE 2002
  • Country
  • PEBO United States
  • GYRE United States
  • Employees
  • PEBO N/A
  • GYRE N/A
  • Industry
  • PEBO Major Banks
  • GYRE Biotechnology: Pharmaceutical Preparations
  • Sector
  • PEBO Finance
  • GYRE Health Care
  • Exchange
  • PEBO Nasdaq
  • GYRE Nasdaq
  • Market Cap
  • PEBO 1.1B
  • GYRE 897.1M
  • IPO Year
  • PEBO N/A
  • GYRE N/A
  • Fundamental
  • Price
  • PEBO $31.56
  • GYRE $7.49
  • Analyst Decision
  • PEBO Buy
  • GYRE
  • Analyst Count
  • PEBO 7
  • GYRE 0
  • Target Price
  • PEBO $36.14
  • GYRE N/A
  • AVG Volume (30 Days)
  • PEBO 184.7K
  • GYRE 188.1K
  • Earning Date
  • PEBO 07-22-2025
  • GYRE 08-12-2025
  • Dividend Yield
  • PEBO 5.19%
  • GYRE N/A
  • EPS Growth
  • PEBO N/A
  • GYRE N/A
  • EPS
  • PEBO 3.15
  • GYRE 0.02
  • Revenue
  • PEBO $561,241,000.00
  • GYRE $100,643,000.00
  • Revenue This Year
  • PEBO N/A
  • GYRE $21.04
  • Revenue Next Year
  • PEBO $3.60
  • GYRE $89.64
  • P/E Ratio
  • PEBO $10.03
  • GYRE $96.96
  • Revenue Growth
  • PEBO 12.39
  • GYRE N/A
  • 52 Week Low
  • PEBO $26.21
  • GYRE $6.11
  • 52 Week High
  • PEBO $37.07
  • GYRE $19.00
  • Technical
  • Relative Strength Index (RSI)
  • PEBO 61.98
  • GYRE 42.81
  • Support Level
  • PEBO $30.37
  • GYRE $7.49
  • Resistance Level
  • PEBO $32.30
  • GYRE $7.80
  • Average True Range (ATR)
  • PEBO 0.66
  • GYRE 0.48
  • MACD
  • PEBO 0.12
  • GYRE 0.07
  • Stochastic Oscillator
  • PEBO 78.55
  • GYRE 40.48

About PEBO Peoples Bancorp Inc.

Peoples Bancorp Inc (Marietta OH) is a financial holding company. As a community bank, it offers a complete line of banking, insurance, investment, and trust solutions through its financial subsidiaries. It offers demand deposit accounts, savings accounts, real estate mortgage loans, merchant credit card transaction processing services, corporate and personal trust services, life, health, property, and casualty insurance products, and brokerage services. The bank also offers telephone and internet-based banking through both personal computers and mobile devices.

About GYRE Gyre Therapeutics Inc.

Gyre Therapeutics Inc is a commercial-stage pharmaceutical company developing and commercializing small-molecule anti-inflammatory and anti-fibrotic drugs targeting organ diseases, focusing specifically on organ fibrosis. The company's commercial-stage products include ETUARY, Avatrombopag, and Nintedanib. In addition, it is focused on the development and commercialization of Hydronidone (F351) for the treatment of Metabolic Dysfunction Associated Steatohepatitis (MASH-associated liver fibrosis (MASH fibrosis). Gyre is also advancing a diverse pipeline of different drug candidates in China, including F573, F528, and F230. The company's reportable segments are Gyre Pharmaceuticals, which derives maximum revenue from the sale of ETUARY and certain generic drugs in the PRC, Gyre, and Other.

Share on Social Networks: